Search Result "N-acetylcarnosine ophthalmic prodrug"
Revival of the Lens Transparency with N-Acetylcarnosine
Journal: Current Drug Therapy
Volume: 1 Issue: 1 Year: 2006 Page: 91-116
Author(s): Mark A. Babizhayev, Anatoly I. Deyev, Valentina N. Yermakova, Valerii V. Remenshchikov, Johan Bours
Current Ocular Drug Delivery Challenges for N-acetylcarnosine: Novel Patented Routes and Modes of Delivery, Design for Enhancement of Therapeutic Activity and Drug Delivery Relationships
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 3 Issue: 3 Year: 2009 Page: 229-265
Author(s): Mark A. Babizhayev
Biomarkers of Oxidative Stress and Cataract. Novel Drug Delivery Therapeutic Strategies Targeting Telomere Reduction and the Expression of Telomerase Activity in the Lens Epithelial Cells with N-Acetylcarnosine Lubricant Eye Drops: Anti-Cataract which Helps to Prevent and Treat Cataracts in the Eyes of Dogs and other Animals
Journal: Current Drug Delivery
Volume: 11 Issue: 1 Year: 2014 Page: 24-61
Author(s): Mark A. Babizhayev,Yegor E. Yegorov
Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 10 Issue: 2 Year: 2016 Page: 82-129
Author(s): Mark A. Babizhayev,Yegor E. Yegorov
Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine),Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl-L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 4 Issue: 3 Year: 2010 Page: 198-230
Author(s): Mark A. Babizhayev, Yegor E. Yegorov
State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Journal: Current Clinical Pharmacology
Volume: 4 Issue: 1 Year: 2009 Page: 4-37
Author(s): Mark A. Babizhayev, Anne Kasus-Jacobi
Senescent Phenotype of Trabecular Meshwork Cells Displays Biomarkers in Primary Open-Angle Glaucoma
Journal: Current Molecular Medicine
Volume: 11 Issue: 7 Year: 2011 Page: 528-552
Author(s): M.A. Babizhayev, Y.E. Yegorov
Diabetes Mellitus: Novel Insights, Analysis and Interpretation of Pathophysiology and Complications Management with Imidazole-Containing Peptidomimetic Antioxidants
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 7 Issue: 3 Year: 2013 Page: 216-256
Author(s): Mark A. Babizhayev,Vadim Z. Lankin,Ekaterina L. SavelâYeva,Anatoliy I. Deyev,Yegor E. Yegorov
Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 3 Year: 2014 Page: 153-179
Author(s): Mark A. Babizhayev,Anne Kasus-Jacobi,Khava S. Vishnyakova,Yegor E. Yegorov
Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 8 Year: 2014 Page: 738-778
Author(s): Mark A. Babizhayev